Author

Louis S. Ates

BioNTech (Germany)ORCID 0000-0002-2953-8010Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:rat· 1

Frequent Co-Authors

Annette B. VogeliD· 1 shared Anuhar ChaturvediiD· 1 shared Charles L. DulbergeriD· 1 shared Jan Diekmann· 1 shared Janina Vogt· 1 shared Mustafa DikeniD· 1 shared Nataša VukoviciD· 1 shared Neha AgrawaliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Annette B. VogelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models

Neha Agrawal, Louis S. Ates, Stefan A. Schille, Anuhar Chaturvedi, Janina Vogt, Nataša Vukovic, Charles L. Dulberger, Annette B. Vogel, Jan Diekmann, Mustafa Diken, Uğur Şahin

This paper describes two mRNA vaccines for tuberculosis that are immunogenic, well-tolerated, and effective in rodent models, entering clinical trials.

Nature Immunology · Jun 12, 2026Peer-reviewedImmunology